Cost-effectiveness of PrEP in HIV/AIDS control in Zambia: a stochastic league approach

Authors :: Brooke E Nichols
Rob Baltussen
Phil E. Thuma
Janneke H. van Dijk
Jan L. Nouwen
Charles A. Boucher
David A. M. C. van de Vijver
Virology
Internal Medicine
Medical Microbiology & Infectious Diseases
Source :: JAIDS Journal of Acquired Immune Deficiency Syndromes, Jaids. Journal of Acquired Immune Deficiency Syndromes, 66(2), 221-228. Lippincott Williams & Wilkins, JAIDS : Journal of Acquired Immune Deficiency Syndromes, 66, 221-8, JAIDS : Journal of Acquired Immune Deficiency Syndromes, 66, 2, pp. 221-8, JAIDS Journal of Acquired Immune Deficiency Syndromes; Vol
Publication Year :: 2014
Abstract: Item does not contain fulltext BACKGROUND: Earlier antiretroviral therapy initiation and pre-exposure prophylaxis (PrEP) prevent HIV, although at a substantial cost. We use mathematical modeling to compare the cost-effectiveness and economic affordability of antiretroviral-based prevention strategies in rural Macha, Zambia. METHODS: We compare the epidemiological impact and cost-effectiveness over 40 years of a baseline scenario (treatment initiation at CD4

Subjects :: medicine.medical_specialty
Cost effectiveness
Anti-HIV Agents
Cost-Benefit Analysis
Population
Developing country
Zambia
HIV Infections
03 medical and health sciences
Pre-exposure prophylaxis
0302 clinical medicine
Acquired immunodeficiency syndrome (AIDS)
SDG 3 - Good Health and Well-being
Interquartile range
Epidemiology
medicine
Prevalence
Humans
Pharmacology (medical)
030212 general & internal medicine
education
health care economics and organizations
030304 developmental biology
0303 health sciences
education.field_of_study
Acquired Immunodeficiency Syndrome
business.industry
Treatment as prevention
medicine.disease
3. Good health
CD4 Lymphocyte Count
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
Infectious Diseases
Models, Economic
Physical therapy
business
Demography

Tools